Section Editor's Notebook: Prostate Cancer Theranosis in Clinical Practice and in Clinical Trials-68Ga-Prostate-Specific Member Antigen (PSMA)-11 PET/CT and 177Lu-PSMA-617 Therapy.
Publication
, Journal Article
Subramaniam, RM
Published in: AJR Am J Roentgenol
August 2019
Duke Scholars
Published In
AJR Am J Roentgenol
DOI
EISSN
1546-3141
Publication Date
August 2019
Volume
213
Issue
2
Start / End Page
241 / 242
Location
United States
Related Subject Headings
- Prostatic Neoplasms
- Prostate-Specific Antigen
- Prospective Studies
- Positron Emission Tomography Computed Tomography
- Oligopeptides
- Nuclear Medicine & Medical Imaging
- Male
- Humans
- Heterocyclic Compounds, 1-Ring
- Gallium Radioisotopes
Citation
APA
Chicago
ICMJE
MLA
NLM
Subramaniam, R. M. (2019). Section Editor's Notebook: Prostate Cancer Theranosis in Clinical Practice and in Clinical Trials-68Ga-Prostate-Specific Member Antigen (PSMA)-11 PET/CT and 177Lu-PSMA-617 Therapy. AJR Am J Roentgenol, 213(2), 241–242. https://doi.org/10.2214/AJR.19.21391
Subramaniam, Rathan M. “Section Editor's Notebook: Prostate Cancer Theranosis in Clinical Practice and in Clinical Trials-68Ga-Prostate-Specific Member Antigen (PSMA)-11 PET/CT and 177Lu-PSMA-617 Therapy.” AJR Am J Roentgenol 213, no. 2 (August 2019): 241–42. https://doi.org/10.2214/AJR.19.21391.
Subramaniam RM. Section Editor's Notebook: Prostate Cancer Theranosis in Clinical Practice and in Clinical Trials-68Ga-Prostate-Specific Member Antigen (PSMA)-11 PET/CT and 177Lu-PSMA-617 Therapy. AJR Am J Roentgenol. 2019 Aug;213(2):241–2.
Subramaniam, Rathan M. “Section Editor's Notebook: Prostate Cancer Theranosis in Clinical Practice and in Clinical Trials-68Ga-Prostate-Specific Member Antigen (PSMA)-11 PET/CT and 177Lu-PSMA-617 Therapy.” AJR Am J Roentgenol, vol. 213, no. 2, Aug. 2019, pp. 241–42. Pubmed, doi:10.2214/AJR.19.21391.
Subramaniam RM. Section Editor's Notebook: Prostate Cancer Theranosis in Clinical Practice and in Clinical Trials-68Ga-Prostate-Specific Member Antigen (PSMA)-11 PET/CT and 177Lu-PSMA-617 Therapy. AJR Am J Roentgenol. 2019 Aug;213(2):241–242.
Published In
AJR Am J Roentgenol
DOI
EISSN
1546-3141
Publication Date
August 2019
Volume
213
Issue
2
Start / End Page
241 / 242
Location
United States
Related Subject Headings
- Prostatic Neoplasms
- Prostate-Specific Antigen
- Prospective Studies
- Positron Emission Tomography Computed Tomography
- Oligopeptides
- Nuclear Medicine & Medical Imaging
- Male
- Humans
- Heterocyclic Compounds, 1-Ring
- Gallium Radioisotopes